Skip to main content

Advertisement

SpringerLink
Log in

Unmet needs in the management of neurourological disorders within the last 50 years

  • Topic Paper
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Purpose

This abstract aims to assess the evolution of neurogenic patient management over the past century, with a focus on persistent unmet needs in the field. We reflect on the history of neurourology and its key principles, highlighting urgent needs for research and progress.

Methods

This review is based on a non-systematic search of MEDLINE databases. We explore the historical context, innovations, and challenges in neurological patient care, using keywords such as “Neurourology”, “history” and “future”, as well as specific treatment modalities.

Result

Several unmet needs in the field of neurourology have been identified. These include the need to strike a balance between spontaneous micturition and continence, the search for solutions to restore spontaneous micturition in patients with acontractile bladders, the imperative to improve and personalize renal and bladder function monitoring, mitigation of the side effects of long-term treatments, strategies to manage recurrent urinary tract infections, and efforts to overcome organizational barriers in patient care.

Conclusion

The care of neurological patients has made remarkable progress over the past 50 years. However, persistent unmet needs underline the need for ongoing research and collaboration to improve the quality of care in this field.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Data availability

Not applicable.

References

  1. - Sanjay S, Hamid R (2020) Fifty years of ics: a brief history of neurourology. ICS News. https://www.ics.org/news/1140. (Accessed 11 Apr 2023)

  2. Mattelaer JJ, Billiet I (1995) Catheters and sounds: the history of bladder catheterisation. Spinal Cord 33(8):429–433. https://doi.org/10.1038/sc.1995.95

    Article  CAS  Google Scholar 

  3. Gharbi M, Gazdovich S, Bazinet A, Cornu JN (2022) Quality of life in neurogenic patients based on different bladder management methods: a review. Prog Urol 32(11):784–808. https://doi.org/10.1016/j.purol.2022.07.004

    Article  CAS  PubMed  Google Scholar 

  4. - Haute Autorité de Santé [HAS] (2014) Betmiga. https://www.has-sante.fr/upload/docs/evamed/CT-13270_BETMIGA_PIC_INS_Avispostaud_CT13270.pdf. (Accessed 13 Apr 2023)

  5. - Food and Drug Administration [FDA] (2012) Myrbetriq. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202611s011lbl.pdf. (Accessed 13 Apr 2023)

  6. Zhang D, Sun F, Yao H, Bao X, Wang D, Cui Y et al (2021) The efficacy and safety of mirabegron for the treatment of neurogenic lower urinary tract dysfunction: a systematic review and meta-analysis. Front Pharmacol 12:756582. https://doi.org/10.3389/fphar.2021.756582

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Akkoc Y (2022) Efficacy and safety of mirabegron for treatment of neurogenic detrusor overactivity in adults with spinal cord injury or multiple sclerosis: a systematic review. Spinal Cord 60(10):854–861. https://doi.org/10.1038/s41393-022-00853-3

    Article  PubMed  Google Scholar 

  8. Longoria V, Parcel H, Toma B, Minhas A, Zeine R (2022) Neurological benefits, clinical challenges, and neuropathologic promise of medical marijuana: a systematic review of cannabinoid effects in multiple sclerosis and experimental models of demyelination. Biomedicines. https://doi.org/10.3390/biomedicines10030539

    Article  PubMed  PubMed Central  Google Scholar 

  9. Michel MC (2020) Where will the next generation of medical treatments for overactive bladder syndrome come from? Int J Urol 27:289–294. https://doi.org/10.1111/iju.14189

    Article  PubMed  Google Scholar 

  10. Phé V, Chartier-Kastler E, Panicker JN (2016) Management of neurogenic bladder in patients with multiple sclerosis. Nat Rev Urol 13(5):275–288. https://doi.org/10.1038/nrurol.2016.53

    Article  CAS  PubMed  Google Scholar 

  11. Sartori AM, Kiss B, Mordasini L, Pollo C, Schüpbach M, Burkhard FC et al (2022) Effects of deep brain stimulation on lower urinary tract function in neurological patients. Eur Urol Focus 8(6):1775–1782. https://doi.org/10.1016/j.euf.2022.05.004

    Article  PubMed  Google Scholar 

  12. Guillot-Tantay C, Chartier-Kastler E, Mozer P, Bitker MO, Richard F, Ambrogi V, Denys P, Léon P, Phé V (2018) Male neurogenic stress urinary incontinence treated by artificial urinary sphincter AMS 800™ (Boston Scientific, Boston, USA): Very long-term results (>25 years). Prog Urol 28(1):39–47. https://doi.org/10.1016/j.purol.2017.09.012

    Article  CAS  PubMed  Google Scholar 

  13. Carson CC (2020) Artificial urinary sphincter: current status and future directions. Asian J Androl 22(2):154–157. https://doi.org/10.4103/aja.aja_5_20

    Article  PubMed  PubMed Central  Google Scholar 

  14. Moro C, Phelps C, Veer V, Clark J, Glasziou P, Tikkinen KAO, Scott AM (2022) The effectiveness of parasympathomimetics for treating underactive bladder: a systematic review and meta-analysis. Neurourol Urodyn 41(1):127–139. https://doi.org/10.1002/nau.24839

    Article  CAS  PubMed  Google Scholar 

  15. - Blok B, Castro-Díaz D, Del Popolo G, Groen J, Hamid R, Karsenty G et al (2022) European Association of Urology [EAU] Guidelines: Neuro-Urology. Edn. presented at the EAU Annual Congress Amsterdam 2022

  16. Guiho T, Azevedo-Coste C, Bauchet L, Delleci C, Vignes JR, Guiraud D, Fattal C (2022) Sacral anterior root stimulation and visceral function outcomes in spinal cord injury—a systematic review of the literature over four decades. World Neurosurg 157:218–232. https://doi.org/10.1016/j.wneu.2021.09.041. (e14)

    Article  PubMed  Google Scholar 

  17. Stenzl A, Ninkovic M, Kölle D, Knapp R, Anderl H, Bartsch G (1998) Restoration of voluntary emptying of the bladder by transplantation of innervated free skeletal muscle. Lancet 351(9114):1483–1485. https://doi.org/10.1016/S0140-6736(97)10005-8

    Article  CAS  PubMed  Google Scholar 

  18. Forte AJ, Boczar D, Huayllani MT, Moran S, Okanlami OO, Ninkovic M, Broer PN (2021) Latissimus dorsi detrusor myoplasty for bladder acontractility: a systematic review. Arch Plast Surg 48(5):528–533. https://doi.org/10.5999/aps.2021.00402

    Article  PubMed  PubMed Central  Google Scholar 

  19. Bayrak Ö, Dmochowski RR (2019) Underactive bladder: a review of the current treatment concepts. Turk J Urol 45(6):401–409. https://doi.org/10.5152/tud.2019.37659

    Article  PubMed  PubMed Central  Google Scholar 

  20. Hartigan SM, Dmochowski RR (2022) The inFlow intraurethral valve-pump for women with detrusor underactivity: a summary of peer-reviewed literature. J Spinal Cord Med 45(4):489–497. https://doi.org/10.1080/10790268.2020.1829415

    Article  PubMed  Google Scholar 

  21. Mingat N, Villar E, Allard J, Castel-Lacanal E, Guillotreau J, Malavaud B, Rischmann P, Tack I, Ruffion A, Gamé X (2013) Prospective study of methods of renal function evaluation in patients with neurogenic bladder dysfunction. Urology 82(5):1032–1037. https://doi.org/10.1016/j.urology.2013.07.027

    Article  PubMed  Google Scholar 

  22. Pavese C, Schneider MP, Schubert M, Curt A, Scivoletto G, Finazzi-Agrò E, Mehnert U, Maier D, Abel R, Röhrich F, Weidner N, Rupp R, Kessels AG, Bachmann LM, Kessler TM (2016) Prediction of bladder outcomes after traumatic spinal cord injury: a longitudinal cohort study. PLoS Med 13(6):e1002041. https://doi.org/10.1371/journal.pmed.1002041

    Article  PubMed  PubMed Central  Google Scholar 

  23. Wang W, Fang H, Xie P, Cao Q, He L, Cai W (2019) Create a predictive model for neurogenic bladder patients: upper urinary tract damage predictive nomogram. Int J Neurosci 129(12):1240–1246. https://doi.org/10.1080/00207454.2019.1655016

    Article  PubMed  Google Scholar 

  24. Dmochowski RR, Thai S, Iglay K, Enemchukwu E, Tee S, Varano S, Girman C, Radican L, Mudd PN Jr, Poole C (2021) Increased risk of incident dementia following use of anticholinergic agents: a systematic literature review and meta-analysis. Neurourol Urodyn 40(1):28–37. https://doi.org/10.1002/nau.24536

    Article  PubMed  Google Scholar 

  25. Bottet F, Peyronnet B, Boissier R, Reiss B, Previnaire JG, Manunta A, Kerdraon J, Ruffion A, Lenormand L, PerrouinVerbe B, Gaillet S, Gamé X, Karsenty G (2018) Groupe d’Etude de Neuro-Urologie de Langue Française and the committee of NeuroUrology of the French Association of Urology [AFU]. Switch to Abobotulinum toxin A may be useful in the treatment of neurogenic detrusor overactivity when intradetrusor injections of Onabotulinum toxin A failed. Neurourol Urodyn 37(1):291–297. https://doi.org/10.1002/nau.23291

    Article  CAS  PubMed  Google Scholar 

  26. Giannantoni A, Gubbiotti M, Rubilotta E, Balzarro M, Antonelli A, Bini V (2022) IncobotulinumtoxinA versus onabotulinumtoxinA intradetrusor injections in patients with neurogenic detrusor overactivity incontinence: a double-blind, randomized, non-inferiority trial. Minerva Urol Nephrol 74(5):625–635. https://doi.org/10.23736/S2724-6051.21.04227-2

    Article  PubMed  Google Scholar 

  27. Wang X, Zhang F, Liao L (2021) Current applications and future directions of bioengineering approaches for bladder augmentation and reconstruction. Front Surg 8:664404. https://doi.org/10.3389/fsurg.2021.664404

    Article  PubMed  PubMed Central  Google Scholar 

  28. Dinh A, Davido B, Duran C, Bouchand F, Gaillard JL, Even A, Denys P, Chartier-Kastler E, Bernard L (2019) Urinary tract infections in patients with neurogenic bladder. Med Mal Infect 49(7):495–504. https://doi.org/10.1016/j.medmal.2019.02.006

    Article  CAS  PubMed  Google Scholar 

  29. Poirier C, Dinh A, Salomon J, Grall N, Andremont A, Bernard L (2016) Prevention of urinary tract infections by antibiotic cycling in spinal cord injury patients and low emergence of multidrug resistant bacteria. Med Mal Infect 46(6):294–299. https://doi.org/10.1016/j.medmal.2016.02.010

    Article  CAS  PubMed  Google Scholar 

  30. Cox L, He C, Bevins J, Clemens JQ, Stoffel JT, Cameron AP (2017) Gentamicin bladder instillations decrease symptomatic urinary tract infections in neurogenic bladder patients on intermittent catheterization. Can Urol Assoc J 11(9):E350–E354. https://doi.org/10.5489/cuaj.4434

    Article  PubMed  PubMed Central  Google Scholar 

  31. Zillioux JM, Jackson JN, Herndon CDA, Corbett ST, Kern NG (2018) Caring for urological transition patients: current practice patterns and opinions. J Pediatr Urol. 14(3):242.e1-242.e5. https://doi.org/10.1016/j.jpurol.2018.02.007

    Article  CAS  PubMed  Google Scholar 

  32. Bower WF, Christie D, DeGennaro M, Latthe P, Raes A, Romao RL, Taghizadeh A, Wood D, Woodhouse CR, Bauer SB (2017) The transition of young adults with lifelong urological needs from pediatric to adult services: An international children’s continence society position statement. Neurourol Urodyn 36(3):811–819. https://doi.org/10.1002/nau.23039

    Article  PubMed  Google Scholar 

  33. Eswara JR, Kielb S, Koyle MA, Wood D, Wood HM (2015) The recommendations of the 2015 American Urological Association Working Group on genitourinary congenitalism. Urology 88:1–7. https://doi.org/10.1016/j.urology.2015.11.019

    Article  PubMed  Google Scholar 

  34. Del Popolo G, Antonucci L (2020) Disability and sustainability: reusable versus single-use catheters for persons with neurogenic bladder due to spinal cord injury. Spinal Cord Ser Cases 6(1):90. https://doi.org/10.1038/s41394-020-00340-y

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Urologie, Sorbonne Université, Hôpital Universitaire Pitié-Salpêtrière, 47-83 Boulevard de L’Hôpital, 75651, Paris Cedex 13, France

    Amélie Bazinet & Emmanuel Chartier-Kastler

  2. Department of Urology, University of Montreal, Maisonneuve-Rosemont Hospital, Montreal, Canada

    Amélie Bazinet

Authors
  1. Amélie Bazinet
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emmanuel Chartier-Kastler
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

AB: project development, data collection, manuscript writing. EC-K: project development, manuscript editing.

Corresponding author

Correspondence to Amélie Bazinet.

Ethics declarations

Ethical standards

Pr. Emmanuel Chartier-Kastler: consultant/investigator at Boston Scientific, Medtronic, Promedon, Uromems, Coloplast, Convatec, BBraun, Wellspect, Uromedica. This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bazinet, A., Chartier-Kastler, E. Unmet needs in the management of neurourological disorders within the last 50 years. World J Urol 41, 3845–3850 (2023). https://doi.org/10.1007/s00345-023-04662-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-023-04662-y

Keywords

Search

Navigation